Good morning :)
Place Order
Add to Watchlist

Global Health Ltd

MEDANTA Share Price

1,345.100.50% (+6.70)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹36,152 cr, stock is ranked 239

Stock is 2.44x as volatile as Nifty

MEDANTA Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is overpriced and in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹36,152 cr, stock is ranked 239

Stock is 2.44x as volatile as Nifty

MEDANTA Performance & Key Metrics

MEDANTA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
75.1012.690.04%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.546.510.80%

MEDANTA Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
71%
Analysts have suggested that investors can buy this stock

from 14 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

MEDANTA Company Profile

Global Health Limited, formerly Global Health Private Limited, is an India-based company. The Company is a tertiary care provider operating in the North and East regions of India. The Company operates approximately four hospitals under Medanta brand

MEDANTA Similar Stocks (Peers)

Compare with peers Compare with peers 

MEDANTA Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
112.37
112.37
1Y Return
33.07%
33.07%
Buy Reco %
75.00
75.00
PE Ratio
73.10
73.10
1Y Return
12.72%
12.72%
Buy Reco %
89.66
89.66
PE Ratio
79.01
79.01
1Y Return
65.97%
65.97%
Buy Reco %
92.86
92.86
PE Ratio
50.41
50.41
1Y Return
57.86%
57.86%
Buy Reco %
70.00
70.00
PE Ratio
77.18
77.18
1Y Return
73.71%
73.71%
Buy Reco %
92.31
92.31
Compare with Peers

MEDANTA Sentiment Analysis

MEDANTA Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

MEDANTA Stock Summary · May 2025

In the fourth quarter, the company demonstrated robust financial performance, achieving a consolidated income of INR 37,714 million, driven by a 13% year-on-year growth and a strong EBITDA margin of 25.4%. Strategic initiatives, including the successful merger with the Lucknow unit and a substantial capital expenditure plan of INR 4,000 crores, are set to enhance operational efficiency and expand bed capacity, addressing the growing healthcare demands in key regions. Despite challenges such as fluctuating average revenue per occupied bed and increased competition, the company remains optimistic about future growth, particularly in underserved markets like Noida and Patna. Enhanced investor engagement and transparency efforts further bolster market sentiment, reflecting confidence in the company’s long-term trajectory.

MEDANTA Stock Growth Drivers
MEDANTA Stock Growth Drivers
7
  • Clinical Excellence and Innovations

    The company has achieved significant milestones in advanced cancer care, including the successful implementation of

  • Financial Performance and Growth

    The company reported a total consolidated income of INR 37,714 million for FY25, reflecting a

MEDANTA Stock Challenges
MEDANTA Stock Challenges
4
  • Challenges in Pre-Engineered Building Adoption

    The company faces significant challenges in adopting pre-engineered buildings in the hospital sector due to

  • Negative Impact of Seasonal Festivals on Operations

    The company has observed a negative impact on elective surgeries during seasonal festivals, including the

MEDANTA Forecast

MEDANTA Forecasts

Price

Revenue

Earnings

MEDANTA

MEDANTA

Income

Balance Sheet

Cash Flow

MEDANTA Income Statement

MEDANTA Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 20%, vs industry avg of 12.95%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 3.56% to 4.74%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 36.19%, vs industry avg of 41.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue1,344.001,392.141,505.821,515.631,255.751,800.002,021.132,382.883,771.413,771.41
Raw Materialssubtract287.89313.43324.92319.21301.73451.23459.11540.962,865.152,865.16
Power & Fuel Costsubtract30.6329.5530.6531.1127.4331.8036.8435.86
Employee Costsubtract518.07526.60540.72522.30415.91494.66532.91591.06
Selling & Administrative Expensessubtract170.86211.56244.28116.95271.25327.42411.71488.02
Operating & Other expensessubtract151.10137.01156.91264.0238.1679.06110.94120.75
Depreciation/Amortizationsubtract77.3586.3690.6998.5787.6487.1786.0987.09193.75193.75
Interest & Other Itemssubtract19.0523.5621.1332.5429.2032.8331.8230.4665.2665.27
Taxes & Other Itemssubtract34.7026.7433.5828.1827.1477.0488.46127.78165.82165.82
EPS2.241.532.574.172.328.7310.1013.4517.9217.93
DPS0.000.000.000.000.000.000.000.000.500.00
Payout ratio0.000.000.000.000.000.000.000.000.030.00

MEDANTA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Feb 13PDF
 

MEDANTA Stock Peers

MEDANTA Past Performance & Peer Comparison

MEDANTA Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Global Health Ltd75.0912.690.04%
Max Healthcare Institute Ltd112.3712.890.12%
Apollo Hospitals Enterprise Ltd73.1014.440.38%
Fortis Healthcare Ltd79.016.670.12%

MEDANTA Stock Price Comparison

Compare MEDANTA with any stock or ETF
Compare MEDANTA with any stock or ETF
MEDANTA
Loading...

MEDANTA Holdings

MEDANTA Shareholdings

MEDANTA Promoter Holdings Trend

MEDANTA Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

MEDANTA Institutional Holdings Trend

MEDANTA Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

MEDANTA Shareholding Pattern

MEDANTA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding33.03%10.36%1.57%11.76%43.28%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

MEDANTA Shareholding History

MEDANTA Shareholding History

Dec '23MarJunSepDec '24Mar11.36%12.09%12.94%12.20%12.47%11.76%

Mutual Funds Invested in MEDANTA

Mutual Funds Invested in MEDANTA

No mutual funds holding trends are available

Top 5 Mutual Funds holding Global Health Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
2.3719%1.49%-0.37%50/70 (-3)
0.8269%1.13%-0.15%47/64 (0)
0.6904%0.95%-0.12%60/117 (-33)

Compare 3-month MF holding change on Screener

MEDANTA Insider Trades & Bulk Stock Deals

MEDANTA Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing MEDANTA stock

smallcases containing MEDANTA stock

Looks like this stock is not in any smallcase yet.

MEDANTA Events

MEDANTA Events

MEDANTA Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

MEDANTA Dividend Trend

No dividend trend available

MEDANTA Dividends

MEDANTA Dividends

Hmm, looks like data is unavailable here. Please come back after some time

MEDANTA Stock News & Opinions

MEDANTA Stock News & Opinions

Spotlight
Volumes jump at Global Health Ltd counter

PCBL Chemical Ltd, Elgi Equipments Ltd, Syrma SGS Technology Ltd, Sammaan Capital Ltd are among the other stocks to see a surge in volumes on NSE today, 09 July 2025.Global Health Ltd saw volume of 48.81 lakh shares by 14:14 IST on NSE, a 19.84 fold spurt over two-week average daily volume of 2.46 lakh shares. The stock increased 5.20% to Rs.1,281.40. Volumes stood at 2.93 lakh shares in the last session.PCBL Chemical Ltd notched up volume of 94.32 lakh shares by 14:14 IST on NSE, a 10.31 fold spurt over two-week average daily volume of 9.15 lakh shares. The stock rose 5.43% to Rs.426.30. Volumes stood at 6.51 lakh shares in the last session.Elgi Equipments Ltd recorded volume of 58.32 lakh shares by 14:14 IST on NSE, a 9.2 times surge over two-week average daily volume of 6.34 lakh shares. The stock gained 4.01% to Rs.555.50. Volumes stood at 32.93 lakh shares in the last session.Syrma SGS Technology Ltd notched up volume of 112.43 lakh shares by 14:14 IST on NSE, a 6.76 fold spurt over two-week average daily volume of 16.64 lakh shares. The stock rose 4.32% to Rs.641.75. Volumes stood at 5.31 lakh shares in the last session.Sammaan Capital Ltd saw volume of 627.72 lakh shares by 14:14 IST on NSE, a 5.35 fold spurt over two-week average daily volume of 117.29 lakh shares. The stock increased 2.13% to Rs.127.75. Volumes stood at 124.1 lakh shares in the last session.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Global Health allots 1.10 lakh equity shares under ESOP

Global Health has allotted 20,000 equity shares under ESOP and 90,000 equity shares under to GHL Employees Welfare Trust ('ESOP Trust') under Part -B of GHL LTIP 2024 Plan i.e. GHL Employees Stock Purchase Scheme, 2024. Post aforesaid allotments, the paid-up share capital of the Company has increased from Rs 53,73,20,764/- divided into 26,86,60,382 equity shares of Rs. 2 each to Rs. 53,75,40,764/- divided into 26,87,70,382 equity shares of Rs. 2/- each.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Global Health consolidated net profit declines 20.40% in the March 2025 quarter

Net profit of Global Health declined 20.40% to Rs 101.40 crore in the quarter ended March 2025 as against Rs 127.38 crore during the previous quarter ended March 2024. Sales rose 15.16% to Rs 931.25 crore in the quarter ended March 2025 as against Rs 808.63 crore during the previous quarter ended March 2024. For the full year,net profit rose 0.68% to Rs 481.44 crore in the year ended March 2025 as against Rs 478.19 crore during the previous year ended March 2024. Sales rose 12.74% to Rs 3692.32 crore in the year ended March 2025 as against Rs 3275.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales931.25808.63 15 3692.323275.11 13 OPM %24.1322.18 -23.7524.40 - PBDT232.59188.54 23 890.91799.83 11 PBT183.34143.09 28 697.16627.10 11 NP101.40127.38 -20 481.44478.19 1 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Board of Global Health recommends final dividend

Global Health announced that the Board of Directors of the Company at its meeting held on 15 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Global Health allots 73,000 equity shares under ESOP

Global Health has allotted 73,000 equity shares to GHL Employee Welfare Trust ('ESOP Trust') under Part -B of GHL LTIP 2024 Plan i.e. GHL Employees Stock Purchase Scheme, 2024. Post allotment, the paid up equity share capital has increased to Rs. 53,73,20,764/- divided into 26,86,60,382 equity shares of Rs. 2/- each.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Global Health to table results

Global Health will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Global Health to set up 400-bed super specialty hospital in North East

Global Health 'Medanta' announced its entry into the North East with its plan to establish a super speciality hospital in Guwahati. The Board of Directors, in its meeting held today, approved the purchase of 3 acres of land from Assam Electricity Grid Corporation for Rs. 30 crore plus incidental expenses for registration and possession of the land. The Board has also approved plans to invest approximately Rs. 500 crore including cost of land in developing a state-of-the-art, 400-bed super specialty hospital. Proposed site is strategically located on National Highway 27, offering seamless connectivity across the entire North East region. This expansion aims to strengthen healthcare infrastructure and will serve over 50 million people across Assam and its neighbouring states. Medanta's foray into the region will be transformative, bringing world-class medical expertise, cutting-edge technology and comprehensive care across more than 20 super specialties, including transplants and advanced robotic procedures. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Global Health grants 5.85 lakh options and offers 2.03 lakh shares under LTIP 2024 Plan

Global Health has approved the grant of 5,85,500 Options and Offer of 2,03,000 Shares to certain eligible employees under Part -A and Part- B of GHL Long Term Share Based Incentive Plan - 2024 (GHL LTIP 2024 Plan), respectively.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Global Health receives land offer from Assam Government for super speciality hospital

The company intends to develop a super speciality hospital on this land. Global Health operates hospitals in Gurugram, Indore, Ranchi, Lucknow and Patna. The company's consolidated operational bed count stood at nearly 2,373 beds as on 31 March 2024. The scrip fell 1.71% to currently trade at Rs 1212 on the BSE. Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Crisil Ratings reaffirms Global Health's 'AA-/A1+' rating with 'positive' outlook

Crisil Ratings stated that GHL's Revenue reported 12% on-year growth in the first nine months of fiscal 2025, driven by increase in inpatient volumes owing to bed expansion, improvement in average revenue per occupied bed (ARPOB) and sustenance of occupancy levels on year on-year basis. Operating profitability moderated by 50 basis points (bps) to 24.1% in the first nine months of fiscal 2025 due to decline in operating profitability in the Lucknow hospital while the Patna (Bihar) and Gurugram (Haryana) hospitals registered stable profitability. At a consolidated level, GHL's revenue may grow 10-12% in fiscal 2025, supported by bed additions, sustenance of occupancy levels at overall level and improvement in ARPOB due to change in case mix. Operating profitability is expected to sustain at 22-24% despite the moderation expected in the Lucknow hospital due to better profitability in other hospitals, although pre-operative expenses towards bed additions at existing hospitals and commencement of the hospital at Noida (Uttar Pradesh) expected towards the end of fiscal 2025 might partly constrain profitability. On consolidated basis, revenue grew 21% to Rs 3,278 crore in fiscal 2024 (from Rs 2,712 crore in fiscal 2023), driven by higher inpatient volumes, changes in specialty mix towards higher value specialties leading to better ARPOB as well as better scale up of the Lucknow and Patna hospitals. The financial risk profile is supported by strong capital structure, healthy debt protection metrics and liquidity. Consolidated adjusted networth stood at Rs 2,900 crore and debt (including lease liabilities) at Rs 802 crore as on 31 March 2024, with gearing at 0.28 time. GHL has planned capital expenditure (capex) of more than Rs ~2,500 crore over the next 3-5 fiscals. The capex will be funded through a prudent mix of cash accrual and debt. Even though the company may avail of external debt, gearing is expected below 0.5 time over the medium term. The ratings continue to reflect the experienced management of GHL in therapeutic segments and healthy financial risk profile. These strengths are partially offset by risks related to implementation and timely stabilisation of upcoming hospitals, geographic and therapeutic segmental concentration in revenue and exposure to intense competition. Global Health operates hospitals in Gurugram, Indore, Ranchi, Lucknow and Patna. The company's consolidated operational bed count stood at nearly 2,373 beds as on 31 March 2024. The scrip shed 0.64% to currently trade at Rs 1227.95 on the BSE. Powered by Capital Market - Live

3 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Global Health Ltd (MEDANTA) today?

    The share price of MEDANTA as on 17th July 2025 is ₹1345.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Global Health Ltd (MEDANTA) share?

    The past returns of Global Health Ltd (MEDANTA) share are
    • Past 1 week: 5.69%
    • Past 1 month: 9.28%
    • Past 3 months: 5.99%
    • Past 6 months: 31.78%
    • Past 1 year: 11.71%
    • Past 3 years: N/A%
    • Past 5 years: 223.89%

  3. What are the peers or stocks similar to Global Health Ltd (MEDANTA)?
  4. What is the dividend yield % of Global Health Ltd (MEDANTA) share?

    The current dividend yield of Global Health Ltd (MEDANTA) is 0.04.

  5. What is the market cap of Global Health Ltd (MEDANTA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Global Health Ltd (MEDANTA) is ₹36152.30 Cr as of 17th July 2025.

  6. What is the 52 week high and low of Global Health Ltd (MEDANTA) share?

    The 52-week high of Global Health Ltd (MEDANTA) is ₹1349 and the 52-week low is ₹935.50.

  7. What is the PE and PB ratio of Global Health Ltd (MEDANTA) stock?

    The P/E (price-to-earnings) ratio of Global Health Ltd (MEDANTA) is 75.09. The P/B (price-to-book) ratio is 12.69.

  8. Which sector does Global Health Ltd (MEDANTA) belong to?

    Global Health Ltd (MEDANTA) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  9. How to buy Global Health Ltd (MEDANTA) shares?

    You can directly buy Global Health Ltd (MEDANTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.